In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 288-16-4, name is Isothiazole, introducing its new discovery. Recommanded Product: Isothiazole
gamma-Secretase Modulators: Current status and future directions
This chapter reviews the current status of gamma-secretase modulators, highlighting key compounds by each company involved in the area. The review focuses on the three main chemotypes: acids, imidazoles and related derivatives and natural products. A section on chemical biology and ligand-binding site elucidation studies is also included. The primary source of information is drawn from peer reviewed literature as this permits analysis of PK-PD relationships and subsequent comment. Discussion of the patent literature is included for completeness. From this analysis, the key issues and challenges in the area are highlighted. The review concludes with a summary of the clinical development status and comment on future prospects of the field.
We¡¯ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, the role of 288-16-4, and how the biochemistry of the body works.Recommanded Product: Isothiazole
Reference£º
Isothiazole – Wikipedia,
Isothiazole – ScienceDirect.com